Dog /

Breed profile · FDA CVM July 2026 extract

Coonhound - Bluetick adverse-event record

Adverse-event filings for Coonhound - Bluetick (Dog) in the FDA Center for Veterinary Medicine openFDA extract. Browse dog breeds, reactions, and outcomes below.

#160 of 510
by report volume (all breeds)
343
FDA CVM reports on file
3.2%
death-coded share of reports
#220 of 275
by death-coded share (≥50 reports)

How the 343 reports break down

By recorded gender -- every report on file for Coonhound - Bluetick, no filtering.

Annual report volume

Annual adverse-event report trend Yearly FDA CVM adverse-event report counts for this breed. 40 30 20 10 0 2019 2020 2021 2022 2023 2024 2025 2026 Reports filed Death-coded reports
Annual report volume for Coonhound - Bluetick drawn from FDA CVM filings.

Data updated September 2026

The verdict

According to the FDA Center for Veterinary Medicine openFDA adverse-event extract, Coonhound - Bluetick ranks #160 of 510 by total reports (343) and #220 of 275 by death-coded share (3.2%). National dual: Retriever - Labrador is #1 of 510 by total adverse-event reports (93,675) at death-coded-share rank 195 of 275 breeds with at least 50 reports (3.7%); separately, Atlantic Salmon (Salmo salar) is #1 highest death-coded share at 99.0% (report rank #233).

93,675
Retriever - Labrador reports (#1)
99.0%
Atlantic Salmon (Salmo salar) death share (#1)
#160
This breed, reports of 510
#220
This breed, death share of 275

Report volume reflects how common a breed or drug is and how often owners and vets file — not actual risk. Death-coded share ranks are limited to entries with enough reports to be meaningful. The two maps do not agree at #1.

Release-over-release change

What changed in the latest FDA data snapshot

PlainBreed reconstructed the prior snapshot from dated openFDA partitions through 2025 Q4, then compared it with the 2026-07-27 openFDA export. Coonhound - Bluetick has 343 reports now versus 335 in that prior snapshot: 8 more (2.4%).

Report change
+8
Death-coded reports
+0
Death-coded share
−0.1 pts

This compares reported-event counts in two source snapshots. It does not establish a change in real-world risk, product safety, or disease incidence.

Subscribe to Coonhound - Bluetick changes

Total Reports

343

Above-median volume

Deaths Reported

11

of 343 reports

Death-coded share of reports

3.2%

Lowest death-coded share

Avg Age at Report

4.3 yr

28.5 kg avg weight

Breed Safety Scorecard

B- (68/100)

A weighted composite across 4 of 4 dimensions, each benchmarked against every tracked breed with at least 200 reports (n=185). Dimensions with insufficient data drop out and their weight redistributes to the rest, so a missing input never silently deflates the score.

Death rate A-
3.2%

Share of reports coded as a fatality

Euthanasia rate A-
1.5%

Share of reports resulting in euthanasia

Full recovery rate F
19.5%

Share of reports coded "Recovered/Normal"

5-year trend A
-29%

Change in annual report volume over the last 5 complete years

Death-Coded Outcome Share

Coonhound - Bluetick death-coded reports 3.2%
Cross-breed median

3.2% of 343 coonhound - bluetick reports involved a death outcome.

How to read this number

Read alongside breed popularity, veterinary access, and owner awareness, these shape how many events ever reach the FDA. The comparison line marks the cross-breed median death-coded share (4.8%) among breeds with 50 or more reports; values above it suggest higher reporting bias toward severe outcomes, not necessarily higher true mortality.

Where Coonhound - Bluetick's death-coded share sits among indexed breeds

Death-coded share of FDA CVM reports, breeds with ≥50 reports (July 2026 extract)

3% 20th percentile Higher share than 20% of 275 indexed breeds

5%–10%: 1 indexed breeds (0%). This entry sits in this band. 20%–25%: 2 indexed breeds (1%). Above this entry. 25%–30%: 3 indexed breeds (1%). Above this entry. 30%–35%: 4 indexed breeds (1%). Above this entry. 35%–40%: 5 indexed breeds (2%). Above this entry. 40%–45%: 6 indexed breeds (2%). Above this entry. 45%–50%: 3 indexed breeds (1%). Above this entry. 50%–55%: 7 indexed breeds (3%). Above this entry. 55%–60%: 7 indexed breeds (3%). Above this entry. 60%–65%: 21 indexed breeds (8%). Above this entry. 65%–70%: 11 indexed breeds (4%). Above this entry. 70%–75%: 15 indexed breeds (5%). Above this entry. 75%–80%: 13 indexed breeds (5%). Above this entry. 80%–85%: 11 indexed breeds (4%). Above this entry. 85%–90%: 12 indexed breeds (4%). Above this entry. 90%–95%: 12 indexed breeds (4%). Above this entry. 95%–100%: 142 indexed breeds (52%). Above this entry. Coonhound - Bluetick 5% 100% every breed with ≥50 FDA reports, bucketed by value

Each bar is a band; taller bars hold more indexed breeds. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source FDA Center for Veterinary Medicine, openFDA adverse event extract (PlainBreed) · July 2026 extract

This histogram uses the same ≥50-report cohort as the highest death-coded share ranking. A higher share means more of this breed's reported events were death-coded, not a mortality rate for living animals.

Average weight at time of report: 28.5 kg (62.8 lbs)

Top Reported Reactions

Lack of efficacy (endoparasite) - heartworm 71
Lack of efficacy (endoparasite) - hookworm 39
Vomiting 37
Lack of efficacy - NOS 26
Lethargy (see also Central nervous system depression in 'Neurological') 21
Emesis 17
INEFFECTIVE, HEARTWORM LARVAE 14
Other abnormal test result NOS 12

Most Referenced Drugs

Milbemycin Oxime + Spinosad 70
Milbemycin Oxime + Praziquantel 56
Moxidectin 55
Pyrantel Pamoate;Sarolaner 40
Ivermectin + Pyrantel As Pamoate Salt 23
Oclacitinib Maleate 20
Melarsomine Dihydrochloride 19
Trilostane 13

Outcome Breakdown

Ongoing
138 (40.2%)
Outcome Unknown
114 (33.2%)
Recovered/Normal
67 (19.5%)
Recovered with Sequela
13 (3.8%)
Died
6 (1.7%)
Euthanized
5 (1.5%)

Gender Distribution

Male 180 (52.5%)
Female 160 (46.6%)
Unknown 2 (0.6%)
Mixed 1 (0.3%)

Reports by Year

Year Reports Trend
2011 1
2012 14
2013 13
2014 14
2015 19
2016 9
2017 23
2018 23
2019 30
2020 26
2021 34
2022 27
2023 40
2024 39
2025 24
2026 7

Coonhound - Bluetick: low death-coded share in the FDA CVM extract

Signature read: Coonhound - Bluetick's 3.2% death-coded share is in the lower third of the ≥50-report cohort (median 4.8%). According to FDA CVM filings indexed on PlainBreed as of July 2026 extract, Coonhound - Bluetick sits at #160 of 510 by report volume among all breeds and #130 of 298 among dog breeds, with 343 reports and 11 (3.2%) death-coded. On death-coded share among breeds with ≥50 reports, it ranks #220 of 275. Mean age at report: 4.3 years, average weight 28.5 kg (62.8 lbs).

Top reported signs: Lack of efficacy (endoparasite) - heartworm (71), Lack of efficacy (endoparasite) - hookworm (39), Vomiting (37). Most-referenced drug: Milbemycin Oxime + Spinosad (70 reports), followed by Milbemycin Oxime + Praziquantel (56) and Moxidectin (55).

Outcome coding on 343 status-recorded reports is dominated by Ongoing (40.2%). Annual submissions ranged 1-2,026 across 16 years on file.

Dog Breeds With a Similar Report Volume

Showing 6 of 297 dog breeds in our dataset, ranked by closest report volume.

Nationwide breeds with similar profiles

High-volume peer sets for Coonhound - Bluetick drawn from openFDA outside the Dog family so the neighborhoods are not species containment (the similar-volume list above stays within species).

Similar death-coded share

Nearest other-species breeds with ≥50 reports (3.2% death-coded here).

Similar average weight

Nearest other-species breeds by reported average weight (28.5 kg here).

What to do with this dog

A report does not prove a drug caused the reaction, and popular breeds simply generate more reports.

Frequently Asked Questions

How many FDA adverse event reports involve Coonhound - Bluetick?
There are 343 adverse event reports involving Coonhound - Bluetick in the FDA database, of which 11 were death-coded (3.2% of those reports). That is a share of REPORTED events, not a mortality rate for the breed: adverse events reach the FDA when something goes wrong, so the denominator is reports, never the population of animals. According to the same FDA CVM extract, Coonhound - Bluetick ranks #160 of 510 by report volume among all breeds PlainBreed indexes (#130 of 298 among dog breeds).
Where does Coonhound - Bluetick sit among other breeds in PlainBreed's corpus?
According to FDA CVM report volume, Coonhound - Bluetick is #160 of 510 breeds indexed on PlainBreed (same ordering as the most-reported-breeds ranking). Inside Dog, it is #130 of 298. Among breeds with at least 50 reports, its death-coded share ranks #220 of 275 (same cohort as highest-death-rate). These are placement ranks in the reporting corpus, not clinical risk scores.
What are the most common adverse reactions reported for Coonhound - Bluetick?
The most commonly reported adverse reactions for Coonhound - Bluetick are Lack of efficacy (endoparasite) - heartworm (71 reports), Lack of efficacy (endoparasite) - hookworm (39 reports), Vomiting (37 reports), Lack of efficacy - NOS (26 reports), Lethargy (see also Central nervous system depression in 'Neurological') (21 reports).
What drugs are most frequently associated with Coonhound - Bluetick adverse events?
The drugs most frequently referenced in Coonhound - Bluetick adverse event reports are Milbemycin Oxime + Spinosad (70 reports), Milbemycin Oxime + Praziquantel (56 reports), Moxidectin (55 reports), Pyrantel Pamoate;Sarolaner (40 reports), Ivermectin + Pyrantel As Pamoate Salt (23 reports).
What is the average age of Coonhound - Bluetick in adverse event reports?
The average age of Coonhound - Bluetick at the time of adverse event reports is 4.3 years, with an average weight of 28.5 kg (62.8 lbs).

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

openFDA Animal & Veterinary Adverse Events (FDA CVM) for Coonhound - Bluetick (Dog), extract as of July 2026 extract. 343 reports · 11 death-coded (3.2% of reports, not a mortality rate) · #160 of 510 by volume.

Informational only. FDA adverse-event reports are voluntary and do not prove causation; consult a veterinarian before acting on them. Verify with FDA CVM →